Yuta Araki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yuta Araki has a total of 105 co-authors. Here are the top co-authors by number of shared publications:
Tamio Suzuki
Department of Dermatology Yamagata University Faculty of Medicine Yamagata Japan
14 shared publications- Ken Okamura
Department of Dermatology, Faculty of Medicine Yamagata University Yamagata Japan
12 shared publications Yutaka Hozumi
Department of Dermatology Faculty of Medicine Yamagata University Yamagata Japan
10 shared publications- Yuko Abe
Department of Dermatology, Faculty of Medicine, Yamagata University, Yamagata, Japan
9 shared publications - Masahiro Hayashi
Department of Dermatology, Faculty of Medicine Yamagata University Yamagata Japan
4 shared publications Masakazu Kawaguchi
Department of Dermatology, Faculty of Medicine, Yamagata University, Yamagata, Japan
3 shared publications
Latest Publications
- 31 May 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (8)
Second Guidelines for the Diagnosis and Treatment of Vitiligo in Japan (2025)
Vitiligo is a common acquired hypopigmented disorder characterized by melanocyte damage and/or loss, primarily resulting from excessive oxidative stress and dysregulated immune responses targeting melanocytes. The initial guidelines for the diagnosis and treatment of vitiligo in Japan were published in Japanese in 2012 and in English in 2013 to provide clinical evidence for vitiligo management. Since then, there has been a substantial accumulation of pathological research and therapeutic evidence. The second guidelines for the diagnosis and treatment of vitiligo in Japan (2025) are presented as an updated resource for clinicians, incorporating worldwide expert recommendations and recent advances in basic and clinical research. These guidelines aim to provide updated knowledge for individuals with vitiligo, public health professionals, scientists, and dermatologists.
- 31 May 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (8)
Second Guidelines for the Diagnosis and Treatment of Vitiligo in Japan (2025)
Vitiligo is a common acquired hypopigmented disorder characterized by melanocyte damage and/or loss, primarily resulting from excessive oxidative stress and dysregulated immune responses targeting melanocytes. The initial guidelines for the diagnosis and treatment of vitiligo in Japan were published in Japanese in 2012 and in English in 2013 to provide clinical evidence for vitiligo management. Since then, there has been a substantial accumulation of pathological research and therapeutic evidence. The second guidelines for the diagnosis and treatment of vitiligo in Japan (2025) are presented as an updated resource for clinicians, incorporating worldwide expert recommendations and recent advances in basic and clinical research. These guidelines aim to provide updated knowledge for individuals with vitiligo, public health professionals, scientists, and dermatologists.
- 5 March 2021
- Published by Oxford University Press (OUP) in Chemistry Letters
- Vol. 50 (3) , 513-517
Ratiometric SERS Assays for Reliable and Automatic Quantification of Nucleic Acids
A novel ratiometric assay was developed for the accurate and facile quantification of nucleic acids using a combination of surface-enhanced Raman scattering (SERS) and two kinds of bioorthogonal Raman reporters attached to SERS probes. Normalization of the SERS intensities of a phenylethynylphenyl group by ethynylphenyl group allows the facile and automatic quantification of target DNA down to 86 pM.
- 5 March 2021
- Published by Oxford University Press (OUP) in Chemistry Letters
- Vol. 50 (3) , 513-517
Ratiometric SERS Assays for Reliable and Automatic Quantification of Nucleic Acids
A novel ratiometric assay was developed for the accurate and facile quantification of nucleic acids using a combination of surface-enhanced Raman scattering (SERS) and two kinds of bioorthogonal Raman reporters attached to SERS probes. Normalization of the SERS intensities of a phenylethynylphenyl group by ethynylphenyl group allows the facile and automatic quantification of target DNA down to 86 pM.
- 6 November 2020
- Published by Wiley in The Journal of Dermatology
- Vol. 48 (2) , E94-E95
Report of two Japanese patients with piebaldism including a novel mutation in KIT
- 6 November 2020
- Published by Wiley in The Journal of Dermatology
- Vol. 48 (2) , E94-E95
Report of two Japanese patients with piebaldism including a novel mutation in KIT
- 27 September 2020
- Published by Wiley in Pigment Cell & Melanoma Research
- Vol. 34 (2) , 174-178
Five novel mutations in SASH1 contribute to lentiginous phenotypes in Japanese families
SASH1 has been reported as a causal gene of lentiginous phenotypes with and without heredity, including an autosomal dominant type characterized by lentigines predominantly on sun‐exposed areas such as the face and limbs. Recently, cases of dyschromatosis with SASH1 mutations have been reported worldwide; however, only one case has been reported from Japan. Here, we analyzed six Japanese patients who characteristically showed many lentigines on sun‐exposed areas, using next‐generation sequencing. We identified five novel heterozygous mutations in SASH1 (p.I586M, p.S531Y, p.R644W, p.T525R, and p.S516I) in our patients and their families. The p.R644W substitution identified in two unrelated families was the first mutation located in the sterile alpha motif 1 (SAM1) domain. The degree and location of the lentigines were variable across individuals, even if they shared the same SASH1 mutation. All mutations were predicted to be deleterious by six different algorithms used to evaluate the functional impact of a variation. In addition, immunohistopathological findings and RNA sequencing results suggested that SASH1 mutations were associated with an increase in the number of melanocytes, acceleration of melanogenesis, and upregulated hair keratin expression.
- 27 September 2020
- Published by Wiley in Pigment Cell & Melanoma Research
- Vol. 34 (2) , 174-178
Five novel mutations in SASH1 contribute to lentiginous phenotypes in Japanese families
SASH1 has been reported as a causal gene of lentiginous phenotypes with and without heredity, including an autosomal dominant type characterized by lentigines predominantly on sun‐exposed areas such as the face and limbs. Recently, cases of dyschromatosis with SASH1 mutations have been reported worldwide; however, only one case has been reported from Japan. Here, we analyzed six Japanese patients who characteristically showed many lentigines on sun‐exposed areas, using next‐generation sequencing. We identified five novel heterozygous mutations in SASH1 (p.I586M, p.S531Y, p.R644W, p.T525R, and p.S516I) in our patients and their families. The p.R644W substitution identified in two unrelated families was the first mutation located in the sterile alpha motif 1 (SAM1) domain. The degree and location of the lentigines were variable across individuals, even if they shared the same SASH1 mutation. All mutations were predicted to be deleterious by six different algorithms used to evaluate the functional impact of a variation. In addition, immunohistopathological findings and RNA sequencing results suggested that SASH1 mutations were associated with an increase in the number of melanocytes, acceleration of melanogenesis, and upregulated hair keratin expression.
- 18 June 2020
- Published by Wiley in Pigment Cell & Melanoma Research
- Vol. 33 (6) , 826-833
Genome‐wide association study identifies CDH13 as a susceptibility gene for rhododendrol‐induced leukoderma
Racemic RS‐4‐(4‐hydroxyphenyl)‐2‐butanol (rhododendrol; trade name: Rhododenol [RD]), which is used in topical skin‐lightening cosmetics, was unexpectedly reported in Japan to induce leukoderma or vitiligo called RD‐induced leukoderma (RIL) after repeated application. To our knowledge, no studies have investigated chemical‐induced vitiligo pathogenesis on a genome‐wide scale. Here, we conducted a genome‐wide association study (GWAS) for 147 cases and 112 controls. CDH13, encoding a glycosylphosphatidylinositol‐anchored protein called T‐cadherin (T‐cad), was identified as the strongest RIL susceptibility gene. RD sensitivity was remarkably increased by T‐cad knockdown in cultured normal human melanocytes. Furthermore, we confirmed tyrosinase upregulation and downregulation of the anti‐apoptotic molecules (BCL‐2 and BCL‐XL), suggesting that T‐cad is associated with RD via tyrosinase or apoptotic pathway regulation. Finally, monobenzyl ether of hydroquinone sensitivity also tended to increase with T‐cad knockdown, suggesting that the T‐cad could be a candidate susceptibility gene for RIL and other chemical‐induced vitiligo forms. This is the first GWAS for chemical‐induced vitiligo, and it could be a useful model for studying the disease's genetic aspects.
- 18 June 2020
- Published by Wiley in Pigment Cell & Melanoma Research
- Vol. 33 (6) , 826-833
Genome‐wide association study identifies CDH13 as a susceptibility gene for rhododendrol‐induced leukoderma
Racemic RS‐4‐(4‐hydroxyphenyl)‐2‐butanol (rhododendrol; trade name: Rhododenol [RD]), which is used in topical skin‐lightening cosmetics, was unexpectedly reported in Japan to induce leukoderma or vitiligo called RD‐induced leukoderma (RIL) after repeated application. To our knowledge, no studies have investigated chemical‐induced vitiligo pathogenesis on a genome‐wide scale. Here, we conducted a genome‐wide association study (GWAS) for 147 cases and 112 controls. CDH13, encoding a glycosylphosphatidylinositol‐anchored protein called T‐cadherin (T‐cad), was identified as the strongest RIL susceptibility gene. RD sensitivity was remarkably increased by T‐cad knockdown in cultured normal human melanocytes. Furthermore, we confirmed tyrosinase upregulation and downregulation of the anti‐apoptotic molecules (BCL‐2 and BCL‐XL), suggesting that T‐cad is associated with RD via tyrosinase or apoptotic pathway regulation. Finally, monobenzyl ether of hydroquinone sensitivity also tended to increase with T‐cad knockdown, suggesting that the T‐cad could be a candidate susceptibility gene for RIL and other chemical‐induced vitiligo forms. This is the first GWAS for chemical‐induced vitiligo, and it could be a useful model for studying the disease's genetic aspects.
- 24 April 2020
- Published by Wiley in The Journal of Dermatology
- Vol. 47 (7) , E250-E251
Case of phaeohyphomycosis caused by Cladophialophora boppii successfully treated with local hyperthermia and systemic terbinafine
- 24 April 2020
- Published by Wiley in The Journal of Dermatology
- Vol. 47 (7) , E250-E251
Case of phaeohyphomycosis caused by Cladophialophora boppii successfully treated with local hyperthermia and systemic terbinafine
- 17 October 2019
- Published by Wiley in The Journal of Dermatology
- Vol. 47 (1) , E20-E21
Speckled lentiginous nevus in a patient with Hermansky–Pudlak syndrome type 1
- 17 October 2019
- Published by Wiley in The Journal of Dermatology
- Vol. 47 (1) , E20-E21
Speckled lentiginous nevus in a patient with Hermansky–Pudlak syndrome type 1
- 22 October 2017
- Published by Wiley in Skin Research and Technology
- Vol. 24 (2) , 175-179
Spectrophotometer is useful for assessing vitiligo and chemical leukoderma severity by quantifying color difference with surrounding normally pigmented skin
Background: Acquired skin hypopigmentation has many etiologies, including autoimmune melanocyte destruction, skin aging, inflammation, and chemical exposure. Distinguishing lesions from normally pigmented skin is clinically important to precisely assess disease severity. However, no gold standard assessment method has been reported. We aimed to investigate whether spectrophotometers are useful for assessing vitiligo and rhododendrol (4‐(4‐hydroxyphenol)‐2‐butanol) (Rhododenol®)‐induced leukoderma disease severity by quantifying skin color.Methods: Mexameter® MX18 and CM‐700d spectrophotometer were used for assessing vitiligo/leukoderma by measuring melanin index, L*a*b* color space, and ΔE*ab value, which represents the color difference between two subjects and is calculated by the values of L*a*b*.Results: MX18 and CM‐700d can quantitatively distinguish vitiligo/leukoderma from normally pigmented skin based on melanin index. CM‐700d consistently quantified the color of vitiligo/leukoderma lesions and surrounding normally pigmented skin in L*a*b* color spaces and ΔE*ab. ΔE*ab is well correlated with melanin index and clinical appearance.Conclusion: ΔE*ab has been frequently used in aesthetic dentistry; however, current study is the first to use it in the measurement of skin color. ΔE*ab seems to be a useful parameter to evaluate the color contrast between vitiligo/leukoderma and surrounding normally pigmented skin and can be used to evaluate disease severity and patient's quality of life.
- 22 October 2017
- Published by Wiley in Skin Research and Technology
- Vol. 24 (2) , 175-179
Spectrophotometer is useful for assessing vitiligo and chemical leukoderma severity by quantifying color difference with surrounding normally pigmented skin
Background: Acquired skin hypopigmentation has many etiologies, including autoimmune melanocyte destruction, skin aging, inflammation, and chemical exposure. Distinguishing lesions from normally pigmented skin is clinically important to precisely assess disease severity. However, no gold standard assessment method has been reported. We aimed to investigate whether spectrophotometers are useful for assessing vitiligo and rhododendrol (4‐(4‐hydroxyphenol)‐2‐butanol) (Rhododenol®)‐induced leukoderma disease severity by quantifying skin color.Methods: Mexameter® MX18 and CM‐700d spectrophotometer were used for assessing vitiligo/leukoderma by measuring melanin index, L*a*b* color space, and ΔE*ab value, which represents the color difference between two subjects and is calculated by the values of L*a*b*.Results: MX18 and CM‐700d can quantitatively distinguish vitiligo/leukoderma from normally pigmented skin based on melanin index. CM‐700d consistently quantified the color of vitiligo/leukoderma lesions and surrounding normally pigmented skin in L*a*b* color spaces and ΔE*ab. ΔE*ab is well correlated with melanin index and clinical appearance.Conclusion: ΔE*ab has been frequently used in aesthetic dentistry; however, current study is the first to use it in the measurement of skin color. ΔE*ab seems to be a useful parameter to evaluate the color contrast between vitiligo/leukoderma and surrounding normally pigmented skin and can be used to evaluate disease severity and patient's quality of life.
- 20 October 2017
- Published by Wiley in Pigment Cell & Melanoma Research
- Vol. 31 (2) , 267-276
Characterization of melanosomes and melanin in Japanese patients with Hermansky–Pudlak syndrome types 1, 4, 6, and 9
Summary: Hermansky–Pudlak syndrome (HPS) is an autosomal recessive disorder characterized by oculocutaneous albinism (OCA), a bleeding tendency, and ceroid deposition. Most of the causative genes for HPS encode subunits of the biogenesis of lysosome‐related organelles complex (BLOC). In this study, we identified one patient each with HPS4, HPS6, and HPS9 by whole‐exome sequencing. Next, we analyzed hair samples from the three patients and representative patients with HPS1 and controls using electron microscopy and chemical methods. All HPS patients had fewer, smaller, and more immature melanosomes than healthy controls. Further, all patients showed reduced total melanin content and increased levels of benzothiazine‐type pheomelanin. The results of this study demonstrate the impact of the dysfunctions of BLOCs on the maturation of melanosomes and melanin levels and composition through analysis of their hair samples.
- 20 October 2017
- Published by Wiley in Pigment Cell & Melanoma Research
- Vol. 31 (2) , 267-276
Characterization of melanosomes and melanin in Japanese patients with Hermansky–Pudlak syndrome types 1, 4, 6, and 9
Summary: Hermansky–Pudlak syndrome (HPS) is an autosomal recessive disorder characterized by oculocutaneous albinism (OCA), a bleeding tendency, and ceroid deposition. Most of the causative genes for HPS encode subunits of the biogenesis of lysosome‐related organelles complex (BLOC). In this study, we identified one patient each with HPS4, HPS6, and HPS9 by whole‐exome sequencing. Next, we analyzed hair samples from the three patients and representative patients with HPS1 and controls using electron microscopy and chemical methods. All HPS patients had fewer, smaller, and more immature melanosomes than healthy controls. Further, all patients showed reduced total melanin content and increased levels of benzothiazine‐type pheomelanin. The results of this study demonstrate the impact of the dysfunctions of BLOCs on the maturation of melanosomes and melanin levels and composition through analysis of their hair samples.
- 1 May 2017
- Published by Elsevier in Journal of Dermatological Science
- Vol. 86 (2) , e52
Behavior of melanocytes and keratinocytes in reticulate acropigmentation of Kitamura
- 1 May 2017
- Published by Elsevier in Journal of Dermatological Science
- Vol. 86 (2) , e52
Behavior of melanocytes and keratinocytes in reticulate acropigmentation of Kitamura